Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Santiago Ribeiro MJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rousseau C, Metz R; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Kerdraon O; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Ouldamer L, Boiffard F; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Renaudeau K; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Ferrer L, Vercouillie J, Doutriaux-Dumoulin I; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Mouton A; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Le Thiec M; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Morel A; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Rusu D; From the ICO René Gauducheau, F-44800, Saint-Herblain, France., Santiago-Ribeiro MJ, Campion L, Arlicot N, Kraeber-Bodéré F; Nantes Université, Univ Angers, CHU Nantes, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France.
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2024 Aug 01; Vol. 49 (8), pp. 701-708. Date of Electronic Publication: 2024 Jun 20.
Autor:
Callaud A; Nuclear Medicine Department, CHRU de Tours, Tours, France., Dupont AC; Nuclear Medicine Department, CHRU de Tours, Tours, France.; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., By MA; Oncology Department, CHRU de Tours, Tours, France., Zemmoura I; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Neurosurgery Department, CHRU de Tours, Tours, France., Santiago-Ribeiro MJ; Nuclear Medicine Department, CHRU de Tours, Tours, France.; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Publikováno v:
Frontiers in nuclear medicine (Lausanne, Switzerland) [Front Nucl Med] 2024 Feb 29; Vol. 4, pp. 1287240. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).
First use of 18 F-FDG PET in TEMPI syndrome: can it be used for treatment assessment? A case report.
Autor:
Pasquesoone H; Nuclear Medicine Department, CHRU TOURS, Tours, France., Callaud A; Nuclear Medicine Department, CHRU TOURS, Tours, France., Carsuzaa T; Nuclear Medicine Department, CHRU TOURS, Tours, France., Chalopin T; Hematology Department, CHRU Tours, Tours, France., Santiago-Ribeiro MJ; Nuclear Medicine Department, CHRU TOURS, Tours, France.; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Publikováno v:
Frontiers in nuclear medicine (Lausanne, Switzerland) [Front Nucl Med] 2023 Oct 26; Vol. 3, pp. 1273967. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).
Autor:
Dupont AC; Radiopharmacie, CHRU de Tours, 37000 Tours, France.; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France., Arlicot N; Radiopharmacie, CHRU de Tours, 37000 Tours, France.; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France.; CIC 1415, Tours University, INSERM, 37000 Tours, France., Vercouillie J; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France., Serrière S; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France., Maia S; Radiopharmacie, CHRU de Tours, 37000 Tours, France.; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France., Bonnet-Brilhault F; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, 37000 Tours, France., Santiago-Ribeiro MJ; UMR 1253, iBrain, Tours University, INSERM, 37000 Tours, France.; Nuclear Medicine Department, CHRU de Tours, 37000 Tours, France.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Aug 10; Vol. 16 (8). Date of Electronic Publication: 2023 Aug 10.
Autor:
Galineau L; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Arlicot N; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Unité de Radiopharmacie, CHRU de Tours, Tours, France., Dupont AC; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Unité de Radiopharmacie, CHRU de Tours, Tours, France.; Service de Médecine Nucléaire, CHRU de Tours, Tours, France., Briend F; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, Tours, France., Houy-Durand E; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, Tours, France., Tauber C; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Gomot M; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, Tours, France., Gissot V; INSERM CIC 1415, CHRU de Tours, Tours, France., Barantin L; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Lefevre A; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Vercouillie J; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Roussel C; INSERM CIC 1415, CHRU de Tours, Tours, France., Roux S; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, Tours, France., Nadal L; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Mavel S; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Laumonnier F; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Belzung C; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Chalon S; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Emond P; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France., Santiago-Ribeiro MJ; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.; Service de Médecine Nucléaire, CHRU de Tours, Tours, France., Bonnet-Brilhault F; UMR 1253, iBrain, Université de Tours, Inserm, Tours, France. frederique.brilhault@univ-tours.fr.; Excellence Center for Autism and Neurodevelopmental Disorders, CHRU de Tours, Tours, France. frederique.brilhault@univ-tours.fr.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2023 Feb; Vol. 28 (2), pp. 801-809. Date of Electronic Publication: 2022 Nov 25.
Autor:
Dupont AC; From the Departments of Nuclear Pharmacy., Borrelly F; Nuclear Medicine., Lecomte T; Hepatology and Gastroenterology, CHRU Hôpitaux De Tours, Tours, France., Maia S; From the Departments of Nuclear Pharmacy., Santiago Ribeiro MJ; Nuclear Medicine.
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2021 Feb 01; Vol. 46 (2), pp. 164-165.
Autor:
Dissaux G; Radiation Oncology Department, University Hospital, Brest, France gurvan.dissaux@chu-brest.fr.; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France., Visvikis D; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France., Da-Ano R; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France., Pradier O; Radiation Oncology Department, University Hospital, Brest, France.; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France., Chajon E; Radiotherapy Department, Centre Eugene Marquis, Rennes, France., Barillot I; Department of Radiation Oncology, University Hospital, Tours, France., Duvergé L; Radiotherapy Department, Centre Eugene Marquis, Rennes, France., Masson I; Department of Radiation Oncology, ICO, Saint-Herblain, France., Abgral R; Nuclear Medicine Department, University Hospital, Brest, France., Santiago Ribeiro MJ; Nuclear Medicine Department, University Hospital, Tours, France., Devillers A; Nuclear Medicine Department, Centre Eugene Marquis, Rennes, France., Pallardy A; Nuclear Medicine Department, University Hospital, Nantes, France; and., Fleury V; Nuclear Medicine Department, ICO, Saint-Herblain, France., Mahé MA; Department of Radiation Oncology, ICO, Saint-Herblain, France., De Crevoisier R; Radiotherapy Department, Centre Eugene Marquis, Rennes, France., Hatt M; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France., Schick U; Radiation Oncology Department, University Hospital, Brest, France.; LaTIM, INSERM, UMR 1101, University of Brest, Brest, France.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2020 Jun; Vol. 61 (6), pp. 814-820. Date of Electronic Publication: 2019 Nov 15.
Autor:
Malherbe C; Radiopharmacy Department, University Hospital of Tours, Tours, France - cecile.malherbe@etu.univ-tours.fr.; François Rabelais University, Tours, France - cecile.malherbe@etu.univ-tours.fr.; UMR Inserm, U930 "Imaging and Brain", Tours, France - cecile.malherbe@etu.univ-tours.fr., Dupont AC; Radiopharmacy Department, University Hospital of Tours, Tours, France.; François Rabelais University, Tours, France.; UMR Inserm, U930 "Imaging and Brain", Tours, France., Maia S; Radiopharmacy Department, University Hospital of Tours, Tours, France.; UMR Inserm, U930 "Imaging and Brain", Tours, France., Venel Y; Nuclear Medicine Department, University Hospital of Tours, Tours, France., Erra B; Nuclear Medicine Department, University Hospital of Tours, Tours, France., Santiago-Ribeiro MJ; François Rabelais University, Tours, France.; UMR Inserm, U930 "Imaging and Brain", Tours, France.; Nuclear Medicine Department, University Hospital of Tours, Tours, France., Arlicot N; Radiopharmacy Department, University Hospital of Tours, Tours, France.; François Rabelais University, Tours, France.; UMR Inserm, U930 "Imaging and Brain", Tours, France.
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2019 Dec; Vol. 63 (4), pp. 371-378. Date of Electronic Publication: 2017 May 03.